These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 35228662)
1. Interactions of Co, Cu, and non-metal phthalocyanines with external structures of SARS-CoV-2 using docking and molecular dynamics. Alencar WLM; da Silva Arouche T; Neto AFG; de Castro Ramalho T; de Carvalho Júnior RN; de Jesus Chaves Neto AM Sci Rep; 2022 Feb; 12(1):3316. PubMed ID: 35228662 [TBL] [Abstract][Full Text] [Related]
2. Interactions between carbon nanotubes and external structures of SARS-CoV-2 using molecular docking and molecular dynamics. Lobato JCM; Arouche TDS; Nero JD; Filho T; Borges RDS; Neto AMJC J Mol Struct; 2023 Aug; 1286():135604. PubMed ID: 37089815 [TBL] [Abstract][Full Text] [Related]
3. 25 (S)-Hydroxycholesterol acts as a possible dual enzymatic inhibitor of SARS-CoV-2 M Alzahrani FA; Alkarim SA; Hawsawi YM; Abdulaal WH; Albiheyri R; Kurdi B; Alguridi H; El-Magd MA J Biomol Struct Dyn; 2023 Jul; 41(10):4744-4755. PubMed ID: 35510619 [TBL] [Abstract][Full Text] [Related]
5. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease. Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340 [TBL] [Abstract][Full Text] [Related]
6. Promising antivirals for PLpro of SARS-CoV-2 using virtual screening, molecular docking, dynamics, and MMPBSA. Kumari R; Kumar V; Dhankhar P; Dalal V J Biomol Struct Dyn; 2023 Jul; 41(10):4650-4666. PubMed ID: 35510600 [TBL] [Abstract][Full Text] [Related]
7. 1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates. Kavitha K; Sivakumar S; Ramesh B Biophys Chem; 2020 Dec; 267():106478. PubMed ID: 33022567 [TBL] [Abstract][Full Text] [Related]
8. Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2. Muhseen ZT; Hameed AR; Al-Hasani HMH; Ahmad S; Li G Molecules; 2021 Jan; 26(3):. PubMed ID: 33525411 [TBL] [Abstract][Full Text] [Related]
9. Molecular interactions of the Omicron, Kappa, and Delta SARS-CoV-2 spike proteins with quantum dots of graphene oxide. da Silva Arouche T; Lobato JCM; Dos Santos Borges R; de Oliveira MS; de Jesus Chaves Neto AM J Mol Model; 2024 Jun; 30(7):203. PubMed ID: 38858279 [TBL] [Abstract][Full Text] [Related]
10. In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors. Ibrahim MAA; Abdelrahman AHM; Allemailem KS; Almatroudi A; Moustafa MF; Hegazy MF Protein J; 2021 Jun; 40(3):296-309. PubMed ID: 33387249 [TBL] [Abstract][Full Text] [Related]
11. Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases. Kumar BK; Faheem ; Sekhar KVGC; Ojha R; Prajapati VK; Pai A; Murugesan S J Biomol Struct Dyn; 2022 Feb; 40(3):1363-1386. PubMed ID: 32981461 [TBL] [Abstract][Full Text] [Related]
12. Pea eggplant ( Govender N; Zulkifli NS; Badrul Hisham NF; Ab Ghani NS; Mohamed-Hussein ZA PeerJ; 2022; 10():e14168. PubMed ID: 36518265 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of multiple SARS-CoV-2 proteins by an antiviral biomolecule, seselin from Nivetha R; Bhuvaragavan S; Muthu Kumar T; Ramanathan K; Janarthanan S J Biomol Struct Dyn; 2022; 40(21):11070-11081. PubMed ID: 34431451 [TBL] [Abstract][Full Text] [Related]
14. Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation. Aziz S; Waqas M; Mohanta TK; Halim SA; Iqbal A; Ali A; Khalid A; Abdalla AN; Khan A; Al-Harrasi A J Infect Public Health; 2023 Apr; 16(4):501-519. PubMed ID: 36801630 [TBL] [Abstract][Full Text] [Related]
15. Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (M Hossain A; Rahman ME; Rahman MS; Nasirujjaman K; Matin MN; Faruqe MO; Rabbee MF Comput Biol Med; 2023 May; 157():106785. PubMed ID: 36931201 [TBL] [Abstract][Full Text] [Related]
16. Identification of terpenoids as potential inhibitors of SARS-CoV-2 (main protease) and spike (RBD) via computer-aided drug design. Hadni H; Fitri A; Touimi Benjelloun A; Benzakour M; Mcharfi M; Benbrahim M J Biomol Struct Dyn; 2024 Sep; 42(15):8145-8158. PubMed ID: 37548619 [TBL] [Abstract][Full Text] [Related]
17. SAR, Molecular Docking and Molecular Dynamic Simulation of Natural Inhibitors against SARS-CoV-2 Mpro Spike Protein. Salamat A; Kosar N; Mohyuddin A; Imran M; Zahid MN; Mahmood T Molecules; 2024 Mar; 29(5):. PubMed ID: 38474656 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 external structures interacting with nanospheres using docking and molecular dynamics. Martins da Silva AY; Arouche TDS; Siqueira MRS; Ramalho TC; de Faria LJG; Gester RDM; Carvalho Junior RN; Santana de Oliveira M; Neto AMJC J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37712854 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19). El-Demerdash A; Metwaly AM; Hassan A; Abd El-Aziz TM; Elkaeed EB; Eissa IH; Arafa RK; Stockand JD Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808721 [TBL] [Abstract][Full Text] [Related]
20. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors. Ibrahim MAA; Abdelrahman AHM; Hussien TA; Badr EAA; Mohamed TA; El-Seedi HR; Pare PW; Efferth T; Hegazy MF Comput Biol Med; 2020 Nov; 126():104046. PubMed ID: 33065388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]